Newsroom | 45270 results
Sorted by: Latest
-
Acadia Healthcare Announces Date for Second Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Wednesday, July 29, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be availabl...
-
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the second quarter 2026 after the close of market on Thursday, July 30, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company’s website and will b...
-
Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026
DALLAS--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its second quarter ended June 30, 2026, on Thursday, August 6, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 7, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com....
-
Anthem Establishes Coverage of C2N Diagnostics’ PrecivityAD2® Blood Test for Alzheimer's Disease Evaluation
ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced that beginning October 1, 2026, eligible Anthem® Blue Cross® and Blue Shield® members will be the first in the United States to receive insurance coverage under a medical policy for the PrecivityAD2® blood test. This policy expands patient access to an innovative blood-based diagnostic test that helps health care professionals evaluate adults exp...
-
Care.com Appoints Chekesha Kidd as General Manager of CareBenefits by Care.com
DALLAS--(BUSINESS WIRE)--Care.com today announced the appointment of Chekesha Kidd as General Manager of CareBenefits by Care.com, the company's employer benefits division helping working families access care support for children, aging parents, and household needs. Kidd brings more than 20 years of senior leadership experience across the employee benefits industry, including roles at Aetna, Delta Dental of Minnesota, and The Hartford, and most recently founded Kinumi, a health and lifestyle pl...
-
LEO Pharma Announces Key Results of Phase 2 TRAPEDS-1 Trial Evaluating Pharmacokinetics and Safety of Tralokinumab in Children With Moderate-to-Severe Atopic Dermatitis
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab...
-
Independent Recognition Reinforces Auragens' Position as a Global Leader in Regenerative Medicine
LAS VEGAS & PANAMA CITY, Panama--(BUSINESS WIRE)--Auragens today announced it has been named Stem Cell Treatment Center of the Year 2026 by Life Sciences Review, becoming the first organization to receive the publication's highest distinction for two consecutive years. While the award recognizes excellence in patient care, it also reflects a broader transformation taking place within regenerative medicine—one in which scientific rigor, manufacturing quality, regulatory oversight, and integrated...
-
Maryland Tech Council Announces New Board of Directors
ROCKVILLE, Md.--(BUSINESS WIRE)--The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today announced the election of new members to its Board of Directors. Bringing decades of expertise across technology, life sciences, and related industries, the directors will help guide MTC’s strategy and planning for the 2-year term. "We are excited to collaborate with this dynamic group of new board members," said Kelly Schulz, CEO of the Maryland Tech...
-
Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis
LA JOLLA, Calif.--(BUSINESS WIRE)--Arialys Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of ANRE...
-
Vega Health and Baptist Health Bring Actionable AI to Hospital at Home, Set Foundation for Long-Term Collaboration
DURHAM, N.C.--(BUSINESS WIRE)--Announcing a partnership between Vega Health and Baptist Health Jacksonville, a multi-hospital health system based in the Southeast...